Home > Insider Trading > Filing (0001209191-22-008025)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1810560	Revelation Biosciences Inc.	REVB	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1287235	F George Tidmarsh	C/O Revelation Biosciences, Inc. 4660 La Jolla Village Dr., Suite 100 San Diego CA 92122		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-02-04	7,900	$2.31	1,481,235	No	4	P	Indirect	By Trust
Common Stock	Acquisiton	2022-02-07	42,100	$2.61	1,523,335	No	4	P	Indirect	By Trust
Common Stock	Acquisiton	2022-02-04	2,000	$2.45	416,156	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Trust
No	4	P	Indirect	By Trust
No	4	P	Direct

Footnotes

Shares are held by George Tidmarsh, Trustee George Francis Tidmarsh 2021 Irrevocable Trust with respect to which George Tidmarsh is a trustee.
Represents the weighted-average price at which shares were purchased within a range between $2.50 and $2.6817. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
The original Form 4, filed on February 8, 2022, is being amended by this Form 4 amendment to include shares purchased directly that were inadvertently omitted in the original filing.